Silvia Mangiacavalli

6PUBLICATIONS
54CO-AUTHORS
Gene and molecular therapyHaematological tumoursMedical infection agents (incl. prions)Immunogenetics (incl. genetic immunology)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2026
Optimizing the Real-World Use of BCMA-Targeted T-Cell-Engaging Therapies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: An Italian Modified Delphi Consensus.

|Aug 18, 2026
Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

|Oct 24, 2025
Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast Nephropathy.

Heinz Ludwig, Meletios Athanasios Dimopoulos, Evangelos Terpos

|Feb 13, 2025
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts.

Mattia D'Agostino, Marina Martello, Lorenzo De Paoli

|Dec 04, 2024
Feasibility of a Biomarker-Based Screening for Pre-Symptomatic AL Amyloidosis in Patients With Intermediate/High-Risk MGUS.

Silvia Mangiacavalli, Paolo Milani, Claudio Salvatore Cartia

|Oct 22, 2016
The possible role of burden of therapy on the risk of myeloma extramedullary spread.

Silvia Mangiacavalli, A Pompa, V Ferretti

Pageof 1

Frequent Collaborators

3 joint publications

Elena Zamagni

3 joint publications

Roberto Mina

2 joint publications

Renato Zambello

2 joint publications

Massimo Offidani